WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Stock Ownership - Who owns Janux Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Janux Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew Hollman MeyerChief Business Officer2025-04-213,334$30.00
$100.02kSell
Andrew Hollman MeyerChief Business Officer2025-04-213,334$4.21
$14.04kBuy
Ra Capital Management LPDirector2025-03-07110,206$31.02
$3.42MBuy
Ra Capital Management LPDirector2025-03-06372,093$30.78
$11.45MBuy
Ra Capital Management LPDirector2025-03-0537,455$31.30
$1.17MBuy
Ra Capital Management LPDirector2025-03-05304,287$30.56
$9.30MBuy
Andrew Hollman MeyerChief Business Officer2025-03-03901$32.85
$29.60kSell
Andrew Hollman MeyerChief Business Officer2025-03-033,334$4.21
$14.04kBuy
Andrew Hollman MeyerChief Business Officer2025-03-032,433$31.89
$77.58kSell
Andrew Hollman MeyerChief Business Officer2025-02-032,418$42.08
$101.74kSell

1 of 12

JANX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JANX insiders and whales buy or sell their stock.

JANX Shareholders

What type of owners hold Janux Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Avalon Ventures XI LP20.06%11,857,257$385.95MInsider
Jay Lichter18.68%11,040,308$359.36MInsider
Ra Capital Management LP17.54%10,365,652$337.40MInstitution
Fmr LLC14.67%8,669,941$282.21MInstitution
Tighe Reardon14.60%8,628,172$280.85MInsider
Bregua Corp6.34%3,749,250$122.04MInsider
Janus Henderson Group PLC6.03%3,562,402$115.96MInstitution
Paradigm Biocapital Advisors LP5.95%3,515,986$114.45MInstitution
Adage Capital Partners GP LLC5.18%3,061,750$99.66MInstitution
Blackrock Inc4.61%2,725,813$88.73MInstitution

1 of 3

JANX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JANX62.97%37.03%Net SellingNet Buying
BLTE0.89%0.00%
KNSA53.45%9.62%Net SellingNet Selling
TARS71.06%28.94%Net SellingNet Selling
VCEL91.07%8.93%Net SellingNet Selling
View Top Biotech Stocks

Janux Therapeutics Stock Ownership FAQ

Who owns Janux Therapeutics?

Janux Therapeutics (NASDAQ: JANX) is owned by 108.50% institutional shareholders, 63.80% Janux Therapeutics insiders, and 0.00% retail investors. Avalon Ventures XI LP is the largest individual Janux Therapeutics shareholder, owning 11.86M shares representing 20.06% of the company. Avalon Ventures XI LP's Janux Therapeutics shares are currently valued at $393.66M.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.